Abstract
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy has become a regular clinical method, while treatment of deep-seated tumors is still at an early stage of development. We present a method for preparing a dedicated patient-specific, computer-optimized treatment plan for electrochemotherapy of deep-seated tumors based on medical images. The treatment plan takes into account the patient’s anatomy, tissue conductivity changes during electroporation and the constraints of the pulse generator. Analysis of the robustness of a treatment plan made with this method shows that the effectiveness of the treatment is not affected significantly by small single errors in electrode positioning. However, when many errors occur simultaneously, the resulting drop in effectiveness is larger, which means that it is necessary to be as accurate as possible in electrode positioning. The largest effect on treatment effectiveness stems from uncertainties in dielectric properties and electroporation thresholds of treated tumors and surrounding tissues, which emphasizes the need for more accurate measurements and more research. The presented methods for treatment planning and robustness analysis allow quantification of the treatment reproducibility and enable the setting of suitable safety margins to improve the likelihood of successful treatment of deep-seated tumors by electrochemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bortfeld T (1999) Optimized planning using physical objectives and constraints. Semin Radiat Oncol 9:20
Campana LG, Mocellin S, Basso M et al (2009) Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 16:191–199
Cemazar M, Jarm T, Miklavcic D et al (1998) Effect of electric-field intensity on electropermeabilization and electrosensitivity of various tumor-cell lines in vitro. Electro Magnetobiol 17:263–272
Corovic S, Zupanic A, Miklavcic D (2008) Numerical modeling and optimization of electric field distribution in subcutaneous tumor treated with electrochemotherapy using needle electrodes. IEEE Trans Plasma Sci 36:1665–1672
Corovic S, Zupanic A, Kranjc S et al (2010) In vivo electroporation detection based on magnetic resonance imaging, propidium iodide fluorescence and numerical modeling of anisotropic muscle tissue. Med Biol Eng Comput 48:637–648
Cukjati D, Batiuskaite D, Andre F et al (2007) Real time electroporation control for accurate and safe in vivo non-viral gene therapy. Bioelectrochemistry 70:501–507
Daniels C, Rubinsky B (2009) Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues. J Biomech Eng 131:071006
Davalos RV, Mir LM, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231
Gabriel S, Lau RW, Gabriel C (1996) The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol 41:2251–2269
Gabriel C, Peyman A, Grant EH (2009) Electrical conductivity of tissue at frequencies below 1 MHz. Phys Med Biol 54:4863–4878
Goldberg A, Rubinsky B (2010) A statistical model for multidimensional irreversible electroporation cell death in tissue. Biomed Eng Online 9:13
Haemmerich D, Schutt DJ, Wright AW et al (2009) Electrical conductivity measurement of excised human metastatic liver tumours before and after thermal ablation. Physiol Meas 30:459–466
Ivorra A, Al-Sakere B, Rubinsky B et al (2009) In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome. Phys Med Biol 54:5949–5963
Marty M, Sersa G, Garbay JR et al (2006) Electrochemotherapy––an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 4:3–13
Miklavcic D, Beravs K, Semrov D et al (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74:2152–2158
Miklavcic D, Semrov D, Mekid H et al (2000) A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523:73–83
Miklavcic D, Corovic S, Pucihar G et al (2006a) Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl 4:45–51
Miklavcic D, Pavselj N, Hart FX (2006b) Electric properties of tissues. In: Wiley encyclopedia of biomedical engineering. John Wiley and Sons, New York
Miklavcic D, Snoj M, Zupanic A et al (2010) Towards treatment planning and treatment of deep seated solid tumors by electrochemotherapy. Biomed Eng Online 9:10
Mir LM, Gehl J, Sersa G et al (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. EJC Suppl 4:14–25
Neal RE, Davalos RV (2009) The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng 37:2615–2625
Orlowski S, Belehradek J, Paoletti C et al (1988) Transient electropermeabilization of cells in culture––increase of the cyto-toxicity of anticancer drugs. Biochem Pharmacol 37:4727–4733
Pavselj N, Miklavcic D (2009) Numerical modeling in electroporation-based biomedical applications. Radiol Oncol 42:159–168
Pavselj N, Bregar Z, Cukjati D et al (2005) The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals. IEEE Trans Biomed Eng 52:1373–1381
Rebersek M, Faurie C, Kanduser M et al (2007) Electroporator with automatic change of electric field direction improves gene electrotransfer in vitro. Biomed Eng Online 6:25
Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6:37–48
Sel D, Cukjati D, Batiuskaite D et al (2005) Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 52:816–827
Sel D, Lebar AM, Miklavcic D (2007) Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization. IEEE Trans Biomed Eng 54:773–781
Sersa G, Cemazar M, Miklavcic D (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 55:3450–3455
Sersa G, Miklavcic D, Cemazar M et al (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34:232–240
Zupanic A, Corovic S, Miklavcic D (2008) Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 42:93–101
Acknowledgement
This research was supported by the Slovenian Research Agency (ARRS) under various grants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kos, B., Zupanic, A., Kotnik, T. et al. Robustness of Treatment Planning for Electrochemotherapy of Deep-Seated Tumors. J Membrane Biol 236, 147–153 (2010). https://doi.org/10.1007/s00232-010-9274-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-010-9274-1